Journal: Archives of internal medicine research
Article Title: Outcomes of Diabetes Management with Continuous Glucose Monitoring Technology
doi: 10.26502/aimr.0243
Figure Lengend Snippet: Comparative summary of leading continuous glucose monitoring platforms. Three commercial CGM systems—Dexcom, Medtronic (MiniMed 780G with Simplera CGM), and FreeStyle Libre—are compared across technology, target population, key clinical trial evidence, advantages, limitations, sensor wear duration, and best-fit clinical scenarios. CGM = continuous glucose monitoring; rtCGM = real-time CGM; MDI = multiple daily injections; T1DM/T2DM = type 1/2 diabetes mellitus; TIR = time in range; ICU = intensive care unit
Article Snippet: This review synthesizes contemporary evidence on continuous glucose monitoring (CGM) systems in the management of Type 1 (T1DM) and Type 2 (T2DM) diabetes mellitus, evaluating clinical, economic, and patient-centered outcomes across the major commercial platforms—Dexcom, Medtronic, and FreeStyle Libre.
Techniques: